f2f4 Search Results


94
Developmental Studies Hybridoma Bank f2f4
F2f4, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/f2f4/product/Developmental Studies Hybridoma Bank
Average 94 stars, based on 1 article reviews
f2f4 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
JENOPTIK Inc microscopic images of the formulations f2, f4, pentravan ® , and celugel
Optical microscopy images of formulations F2, F4, Pentravan ® , and <t>Celugel</t> (magn. 40×).
Microscopic Images Of The Formulations F2, F4, Pentravan ® , And Celugel, supplied by JENOPTIK Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microscopic images of the formulations f2, f4, pentravan ® , and celugel/product/JENOPTIK Inc
Average 90 stars, based on 1 article reviews
microscopic images of the formulations f2, f4, pentravan ® , and celugel - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
AbbVie Inc ifn + rbv + pi for f2–f4
Study characteristics
Ifn + Rbv + Pi For F2–F4, supplied by AbbVie Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ifn + rbv + pi for f2–f4/product/AbbVie Inc
Average 90 stars, based on 1 article reviews
ifn + rbv + pi for f2–f4 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Syngenta compounds f2, f4, f8, and f9
Study characteristics
Compounds F2, F4, F8, And F9, supplied by Syngenta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compounds f2, f4, f8, and f9/product/Syngenta
Average 90 stars, based on 1 article reviews
compounds f2, f4, f8, and f9 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
MiddleBrook Pharmaceuticals fractions f2–f4 (c10–c50)
Study characteristics
Fractions F2–F4 (C10–C50), supplied by MiddleBrook Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fractions f2–f4 (c10–c50)/product/MiddleBrook Pharmaceuticals
Average 90 stars, based on 1 article reviews
fractions f2–f4 (c10–c50) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Merck & Co silica gel 60 f2f4 thin layer chromatography plate
Study characteristics
Silica Gel 60 F2f4 Thin Layer Chromatography Plate, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/silica gel 60 f2f4 thin layer chromatography plate/product/Merck & Co
Average 90 stars, based on 1 article reviews
silica gel 60 f2f4 thin layer chromatography plate - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Optical microscopy images of formulations F2, F4, Pentravan ® , and Celugel (magn. 40×).

Journal: Pharmaceuticals

Article Title: Evaluation of the In Vitro Permeation Parameters of Topical Diclofenac Sodium from Transdermal Pentravan ® Products and Hydrogel Celugel Through Human Skin

doi: 10.3390/ph18060810

Figure Lengend Snippet: Optical microscopy images of formulations F2, F4, Pentravan ® , and Celugel (magn. 40×).

Article Snippet: The microscopic images of the formulations F2, F4, Pentravan ® , and Celugel were performed with Leica DM IL-Led (Leica, Wetzlar, Germany) with N Plan Fluor 40×/0.60 lens optical microscope equipped with JENOPTIK GRYPHAX ProgRes camera (JENOPTIK, Jena, Germany).

Techniques: Microscopy

Study characteristics

Journal: Public Health Reviews

Article Title: Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis

doi: 10.1186/s40985-018-0093-8

Figure Lengend Snippet: Study characteristics

Article Snippet: Ethgen et al. [ ] , France , Hepatitis C (HCV) , 1. IFN + RBV + PI for F2–F4 2. IFN-based DAAs for F2–F4 3. All-oral, IFN-free DAAs for F2–F4 4. All-oral, IFN-free DAAs for F0–F4 , No intervention , French baby-boomer population (1945–1965 birth cohorts) , 20 years , Healthcare , 4% , EUR (no year) , QALYs, liver-related deaths , No , HCV screening and access to all-oral DAAs is CE , AbbVie , Yes.

Techniques: Magnetic Resonance Imaging, Biomarker Discovery, Virus, Computed Tomography, Diagnostic Assay, Infection, Imaging, Modification, Histopathology, Western Blot, Tomography, Staining, Isolation, Control